← Browse by Condition
Medical Condition

pemphigus vulgaris

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06581562 Phase 1
Recruiting

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Enrollment
30 pts
Location
United States
Sponsor
IRIS Research and Development,...
View Trial →